Bobrow and Eltzschig (IMAGE)

University of Texas Health Science Center at Houston

Bobrow and Eltzschig

Caption

Ben Bobrow, MD, and Holger Eltzschig, MD, PhD, used the hypoxia chamber to discover that HIF activators could potentially treat damaged lungs.

Credit

Cody Duty/UTHealth

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.